期刊文献+

尾加压素Ⅱ对人晶状体上皮细胞一氧化氮合成的影响

Effect of urotensin Ⅱ on synthesis of nitric oxide in human lens epithelial cells
下载PDF
导出
摘要 目的探讨新型生物活性物质尾加压素Ⅱ(UrotensinⅡ,U-Ⅱ)对人晶状体上皮细胞(human lens epithelial cells,HLEC)内一氧化氮合酶(nitric oxide sythase,NOS)活性及一氧化氮(nitric oxide,NO)合成的影响。方法用不同浓度的U-Ⅱ(1×10-9mol.L-1、10×10-9mol.L-1、100×10-9mol.L-1)干扰体外培养的HLEC,采用化学比色法和硝酸还原酶法测定HLEC内NOS活性和NO含量。结果空白对照组、(1×10-9mol.L-1、10×10-9mol.L-1、100×10-9mol.L-1)U-Ⅱ组的NOS活力值分别为(3.407±0.168)U.mg-1、(4.058±0.169)U.mg-1、(4.921±0.298)U.mg-1和(5.598±0.897)U.mg-1;NO含量分别为(0.747±0.183)μmol.g-1、(1.238±0.232)μmol.g-1、(1.531±0.101)μmol.g-1、(1.850±0.114)μmol.g-1。与空白对照组相比,U-Ⅱ呈浓度依赖性增强细胞内的NOS活性,刺激NO合成,差异均有显著统计学意义(均为P<0.01)。结论 U-Ⅱ可使HLEC内NOS活性增强和NO生成增多,提示U-Ⅱ可能通过NOS/NO途径促进HLEC增殖。 Objective To investigate the effect of new bioactive substance urotensin Ⅱ(U-Ⅱ)on activity of nitric oxide synthase(NOS)and synthesis of nitric oxide(NO)in human lens epithelial cells(HLEC).Methods The HLEC cultured in vitro were interfered with different concentrations of U-Ⅱ(1×10-9 mol·L-1,10×10-9 mol·L-1,100×10-9 mol·L-1),the NOS activity and NO level in HLEC were detected by chemical colorimetry and nitric acid reductase method,respectively.Results The NOS activity were(3.407±0.168)U·mg-1,(4.058±0.169)U·mg-1,(4.921±0.298)U·mg-1 and(5.598±0.897)U·mg-1 in control group,10-9 mol·L-1,10×10-9 mol·L-1,100×10-9 mol·L-1 U-Ⅱ groups,and the NO level were(0.747±0.183)μmol·g-1,(1.238±0.232)μmol·g-1,(1.531±0.101)μmol·g-1 and(1.850±0.114)μmol·g-1,respectively.Compared with control group,U-Ⅱ enhanced the NOS activity and NO synthesis obviously in a dose-dependent manner,and there were significant differences(all P0.01).Conclusion U-Ⅱ enhances the NOS activity and NO synthesis,which shows U-Ⅱ may promote the proliferation of HLEC through NOS/NO pathway.
出处 《眼科新进展》 CAS 北大核心 2011年第2期113-114,118,共3页 Recent Advances in Ophthalmology
基金 福建省中医药重点项目基金资助(编号:wzzb0601)~~
关键词 尾加压素Ⅱ 人晶状体上皮细胞 增殖 一氧化氮 一氧化氮合酶 urotensin Ⅱ human lens epithelial cell proliferation nitric oxide nitric oxide synthase
  • 相关文献

参考文献10

二级参考文献96

  • 1白芳,秦莉,李小珩.人晶状体上皮细胞体外培养方法的改良[J].新乡医学院学报,2006,23(2):159-161. 被引量:4
  • 2何海鹰,王波,贾维红,梁康,张昌颖.亚硒酸钠诱发的晶状体上皮细胞DNA损伤及修复[J].生物化学杂志,1996,12(3):253-257. 被引量:4
  • 3袁爱花,梅妍,周鸿鹰,项涛,羊惠君.一氧化氮合酶在糖尿病大鼠视网膜中表达模式的研究[J].南方医科大学学报,2007,27(4):454-457. 被引量:5
  • 4张琼,张士胜,王玲.一氧化氮与血管生成的研究进展[J].国际眼科杂志,2007,7(3):788-790. 被引量:13
  • 5张勇刚 杨军 等.尾加压素Ⅱ在心血管系统中的作用[J].北京医科大学学报,2000,32(2):133-133.
  • 6Matsushita M, Shichiri M, Fukai N, et al. Urotensin II is an autocrine/paracrine growth factor for the porcine renal epithelial cell line. Endocrinology 2003 ; 144 ( 5 ) : 1825-1831.
  • 7Maguire JJ, Kue RE, Davenport AP. Ophen-receptor ligand human urotensin II : receptor localization in human tissues and comparison of vasoconstrictor responses with endothelin-1. Br J Pharmacol 2000; 131 (3) :441-446.
  • 8[1]Coulouarn Y, Lihrman I, Jegou S, Anouar Y, Tostivint H, Beauvillain JC, Conlon JM, Bern HA, Vaudry H. Cloning of cDNA encoding the urotensinⅡprecursor in frog and human reveals intense expression of the urotensinⅡgene in motoneurons of the spinal cord. Proc Natl Acad Sci USA, 1998, 95:15803~15808.
  • 9[2]Ames RS, Sarau HM, Chambers JK, Willette RN, Aiyar NV, Romanic AN, Louden CS, Foley JJ, Sauermelch CF, Coatney RW, Ao Z, Disa J, Holmes SD, Stadel JM, Martin JD, Liu WS, Glover GI, Wilson S, Mcnulty DE, Ellis CE, Elshouragy NA, Shabon U, Trill JJ, Hay DWP, Ohlstein EH, Bergsma DJ, Douglas SA. Human urotensin-Ⅱis a potent vasoconstrictor and agonist for the orphan receptor GPR14. Nature, 1999, 401(6750):282~286.
  • 10[3]Russell FD, Molenaar P, O′Brien DM. Cardiostimulant effects of urotensin-Ⅱin human heart in vitro. Br J Pharmacol, 2001,132:5~9.

共引文献75

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部